$Sunstone Hotel Investors(SHO.US)$營收在2020年大幅萎縮76%,之後兩年快速恢復,2022年達到2019年的82%,營業利潤在2020和2021年虧損兩年,2022年扭虧達到2019年的61%,淨利潤也類似,2022年達到2019年的63%。 2023前兩季度營收增長22.7%,營業利潤增長99.3%,受利息費用大幅增加和資產出售收益減少影響,淨利潤僅增長21.5%。 目前市盈率26.6,市盈率TTM下降到21.5,如果不計算疫情的兩年,另外3年平均淨利潤爲1.6億,對應市盈率爲11.7,股息率2.2%,市淨率1.03,綜合來看吸引力不大。
Gainers: In reaction to earnings/guidance: •$Silvergate Capital(SI.US)$+10.7% (Silvergate (ticker: SI) notched net income of $38.6 million in the June quarter, delivering earnings per share (EPS) of $1.13.) •$AxoGen(AXGN.US)$+3.3% (guides Q2 revs above consensus; also makes changes to its commercial organization), •$諾華製藥(NVS.US)$+ 3% (The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from...
Sunstone Hotel Investors股票討論區
2023前兩季度營收增長22.7%,營業利潤增長99.3%,受利息費用大幅增加和資產出售收益減少影響,淨利潤僅增長21.5%。
目前市盈率26.6,市盈率TTM下降到21.5,如果不計算疫情的兩年,另外3年平均淨利潤爲1.6億,對應市盈率爲11.7,股息率2.2%,市淨率1.03,綜合來看吸引力不大。
專欄Today's pre-market stock movers: NFLX, IBM, LMT, SI and more
In reaction to earnings/guidance:
• $Silvergate Capital(SI.US)$ +10.7% (Silvergate (ticker: SI) notched net income of $38.6 million in the June quarter, delivering earnings per share (EPS) of $1.13.)
• $AxoGen(AXGN.US)$ +3.3% (guides Q2 revs above consensus; also makes changes to its commercial organization),
• $諾華製藥(NVS.US)$ + 3% (The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from...
looks good, on track with reopenings
暫無評論